How much revenue does Eyebright Medical Technology (Beijing) make?

Eyebright Medical Technology (Beijing) reported 1.41 billion CNY in revenue for fiscal year 2024, up 48.2% from 951.18 million CNY in fiscal year 2023. In Q2 2025 revenue was 429.51 million CNY.

Where does Eyebright Medical Technology (Beijing) make most of its revenue?

China: 93% of revenue by region in fiscal year 2025, followed by Overseas (7%).

What companies are similar to Eyebright Medical Technology (Beijing)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Micro-Tech (Nanjing) Co.,Ltd (688029.SS), Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS), Autek China Inc. (300595.SZ), Mingyue Optical Lens Co.,Ltd. (301101.SZ).

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) Stock

About Eyebright Medical Technology (Beijing) Co., Ltd.

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company provides intraocular lens, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also offers solutions for ...

At a glance

Eyebright Medical Technology (Beijing) reported revenue of 1.41 billion CNY for fiscal year 2024, up 48.2% from fiscal year 2023, and net income of 388.40 million CNY. In Q2 2025 (the quarter ended June 30, 2025) revenue was 429.51 million CNY, up 14.4% from a year before. China was its largest region in fiscal year 2025, with 93% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2024.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.